Dr. Marks on the Role of TKIs in HER2-Positive Breast Cancer
September 4th 2019
Douglas K. Marks, MD, clinical instructor, Department of Medicine, Perlmutter Cancer Center, NYU Langone Health, discusses the role of TKIs in HER2-positive breast cancer.